Outlook Therapeutics stock price
NASDAQ:OTLK · Nasdaq · Healthcare · sector #16Outlook Therapeutics's chart data is dated 2026-10-21. Recorded technical signals: MACD bullish cross. The display ticker is OTLK.
Outlook Therapeutics last closed at $0.5613 (+7.94%) on 2026-10-21. Signals today: MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is -0.2×. Its overall grade ranks 138 of 727 stocks in Healthcare.
About this company
Outlook Therapeutics last closed at $0.5613 (+7.94%) on 2026-10-21. Signals today: MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A · 138/727
Valuation grade A-
Related stocks
- Regeneron PharmaceuticalsCompetitor
- RocheCompetitor
- NovartisCompetitor
About Outlook Therapeutics
- What technical signals does Outlook Therapeutics (OTLK) have?
- Outlook Therapeutics current technical signals: MACD bullish cross.
- Is Outlook Therapeutics a cup-and-handle pattern?
- No. Outlook Therapeutics has no valid Cup signal right now.
- What published figures are available for Outlook Therapeutics?
- Market cap: $35.99M. Trailing 12 months PER: -0.2×. Latest quarter PBR: -1.38×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Outlook Therapeutics, or open the plan table on the main site.
Ask Q about Outlook Therapeutics.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.